Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interviews as Topic × Head & Neck × Clear all

Phase

Status

Completed 6 Recruiting 5 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 4 Breast 3 Tumor-Agnostic 2 CNS 2 Other hematologic neoplasm 1 Head & Neck 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1

Conditions

Laryngeal Diseases 1

Interventions

pembrolizumab 46 Cisplatin 41 Cetuximab 33 Radiotherapy 27 Radiotherapy, Intensity-Modulated 16 Fluorouracil 16 Docetaxel 15 Nivolumab 14 Carboplatin 14 Paclitaxel 13 Radiation 12 Surgical Procedures, Operative 7 Radiosurgery 7 Gemcitabine 7 Everolimus 7 Cyclophosphamide 7 Biopsy 7 avelumab 5 Surveys and Questionnaires 5 Magnetic Resonance Spectroscopy 5 Celecoxib 5 epacadostat 4 durvalumab 4 bempegaldesleukin 4 Gefitinib 4 Erlotinib Hydrochloride 4 Dexamethasone 4 Capecitabine 4 Amifostine 4 spartalizumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01647477 2026-03-13

DEREDIA

Centre Oscar Lambret

Phase NA Terminated

Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡